FeesSafety
Pluang+

Pfizer set to pay its 352nd consecutive dividend on Dec 7, 2026, despite patent cliff risks.

Company Fundamentals
19 Nov 2026, 11:44 WIB
The Motley Fool
View Source
Neutral
Pfizer set to pay its 352nd consecutive dividend on Dec 7, 2026, despite patent cliff risks.

Pfizer will pay its 352nd consecutive quarterly dividend on December 7, 2026, maintaining a long-standing payout streak. Although the company faces challenges like a patent cliff, costly acquisitions, and clinical trial setbacks, it currently has enough cash reserves and promising new drugs to sustain dividends. Analysts believe all these risks would need to occur simultaneously to stop the dividend, making a cut unlikely. Pfizer remains a strong choice for investors seeking steady income.

Pfizer's stock price on Pluang is USD 27.97 as of November 19, 2026, showing a slight decline of 0.32% that day. The company offers a dividend yield of 6.04%, appealing to income-focused investors. Trading volume reached over 35 million shares, reflecting active market interest at that time.

More News (PFE)

Pfizer set to pay its 352nd consecutive dividend on Dec 7, 2026, despite potential challenges ahead.

Pfizer set to pay its 352nd consecutive dividend on Dec 7, 2026, despite potential challenges ahead.

Pfizer will pay its 352nd consecutive quarterly dividend on December 7, 2026, maintaining a strong track record for investors. The company faces challenges like a patent cliff, costly acquisitions, and clinical setbacks that could threaten this strea...

Company Fundamentals
Neutral
40 minutes ago
Pfizer's strong Q3 and raised 2026 EPS guidance ease patent expiration fears, keeping it a Buy for investors.

Pfizer's strong Q3 and raised 2026 EPS guidance ease patent expiration fears, keeping it a Buy for investors.

Pfizer Inc. delivered strong Q3 results driven by its oncology portfolio, Eliquis, and tafamidis franchise, with Eliquis revenue growing 25.2% year-over-year to about $2.5 billion. Despite concerns about an upcoming patent expiration cycle lasting ar...

Company Fundamentals
Bullish
1 day ago
Pfizer beats Q3 revenue estimates, raises 2026 guidance, and shows strong margin growth.

Pfizer beats Q3 revenue estimates, raises 2026 guidance, and shows strong margin growth.

Pfizer reported Q3 revenue of $16.58 billion, exceeding estimates by $700 million, driven by a 32% growth in launched and acquired products and an improved gross margin of about 77%. The company raised its full-year 2026 revenue guidance to $62 billi...

Analyst Insights
Bullish
1 day ago
Three overlooked dividend stocks now yield over 5%, offering strong income potential with varied risk profiles.

Three overlooked dividend stocks now yield over 5%, offering strong income potential with varied risk profiles.

Three dividend stocks in healthcare, telecom, and financials—Pfizer, Verizon, and OneMain Holdings—currently yield over 5%, attracting income investors seeking high payouts. Pfizer offers a 5.94% yield with growing drug franchises but has tight free ...

Market News
Neutral
1 day ago
Conagra cuts dividend by 50% amid cash flow struggles, signaling market warning on sustainability.

Conagra cuts dividend by 50% amid cash flow struggles, signaling market warning on sustainability.

Conagra Brands cut its quarterly dividend from $0.35 to $0.175 due to negative free cash flow and high leverage, reflecting financial stress. The stock has declined over 38% in five years, showing market skepticism about dividend sustainability witho...

Market News
Bearish
1 day ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App